A study to assess the drug absorption into the blood after administration of 3 doses of AZD5718

Trial Identifier:	D7550C00009
Sponsor:	AstraZeneca
Collaborator:	Parexel
NCTID::	NCT04087187
Start Date:	September 2019
Primary Completion Date:	October 2019
Study Completion Date:	October 2019
Condition:	Coronary Artery Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	London, United Kingdom, HA1 3UJ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.